Collectively, our results provide novel evidence that signaling pathways engaged by deregulated RTKs in CRC, including those reliant on Grb2 or Shc, may represent important regulators of anoikis resistance in IECs, a process of outmost relevance in cancer metastasis. Here, GRB2 is linked to cancer.